The administration of four-factor prothrombin complex concentrate exacerbates thrombin generation in trauma patients at risk of massive transfusion: an ancillary study of the PROCOAG trial

被引：2
|
作者：
Greze, Jules [1 ]
Marlu, Raphael [2 ]
Baud, Mariette [1 ]
Seyve, Landry [3 ]
Gauss, Tobias [1 ]
Bouzat, Pierre [1 ,4 ]
机构：
[1] Univ Grenoble Alpes, Grenoble Inst Neurosci, Inserm, U1216,CHU Grenoble Alpes, F-38000 Grenoble, France
[2] Univ Grenoble Alpes, Hemostasis Lab, CNRS TIMC UMR5525, CHU Grenoble Alpes, F-38000 Grenoble, France
[3] CHU Grenoble Alpes, Hemostasis Lab, F-38000 Grenoble, France
[4] Hop Albert Michallon, Pole Anesthesie Reanimat, BP 217, F-38043 Grenoble, France
来源：
CRITICAL CARE | 2024年 / 28卷 / 01期
关键词：
D O I：
10.1186/s13054-024-04836-z
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] The administration of four-factor prothrombin complex concentrate exacerbates thrombin generation in trauma patients at risk of massive transfusion: an ancillary study of the PROCOAG trial
    Jules Greze
    Raphael Marlu
    Mariette Baud
    Landry Seyve
    Tobias Gauss
    Pierre Bouzat
    Critical Care, 28
  • [2] Efficacy and Safety of Early Administration of 4-Factor Prothrombin Complex Concentrate in Patients With Trauma at Risk of Massive Transfusion The PROCOAG Randomized Clinical Trial
    Bouzat, Pierre
    Charbit, Jonathan
    Abback, Paer-Selim
    Huet-Garrigue, Delphine
    Delhaye, Nathalie
    Leone, Marc
    Marcotte, Guillaume
    David, Jean-Stephane
    Levrat, Albrice
    Asehnoune, Karim
    Pottecher, Julien
    Duranteau, Jacques
    Courvalin, Elie
    Adolle, Anais
    Sourd, Dimitri
    Bosson, Jean-Luc
    Riou, Bruno
    Gauss, Tobias
    Payen, Jean-Francois
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (16): : 1367 - 1375
  • [3] Four-factor prothrombin complex concentrate in trauma patients
    Bouzat, Pierre
    Hunt, Beverley J. J.
    Juffermans, Nicole P. P.
    INTENSIVE CARE MEDICINE, 2023, 49 (10) : 1242 - 1244
  • [4] Four-factor prothrombin complex concentrate in trauma patients
    Pierre Bouzat
    Beverley J. Hunt
    Nicole P. Juffermans
    Intensive Care Medicine, 2023, 49 : 1242 - 1244
  • [5] Four-Factor Prothrombin Complex Concentrate for Patients With Trauma
    Hsu, Chia-Hao
    Chou, Pei-Hsi
    Hsu, Nin-Chieh
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (09): : 875 - 875
  • [6] Four-factor prothrombin complex concentrate to reduce allogenic blood product transfusion in patients with major trauma, the PROCOAG trial: study protocol for a randomized multicenter double-blind superiority study
    Bouzat, Pierre
    Bosson, Jean-Luc
    David, Jean-Stephane
    Riou, Bruno
    Duranteau, Jacques
    Payen, Jean-Francois
    TRIALS, 2021, 22 (01)
  • [7] Four-factor prothrombin complex concentrate to reduce allogenic blood product transfusion in patients with major trauma, the PROCOAG trial: study protocol for a randomized multicenter double-blind superiority study
    Pierre Bouzat
    Jean-Luc Bosson
    Jean-Stéphane David
    Bruno Riou
    Jacques Duranteau
    Jean-François Payen
    Trials, 22
  • [8] Four-Factor Prothrombin Complex Concentrate for Patients With Trauma-Reply
    Bouzat, Pierre
    Gauss, Tobias
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (09): : 876 - 876
  • [9] THROMBOEMBOLIC RISK OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE IN CANCER PATIENTS
    Akella, Padmastuti
    Tao, Jing
    Pastores, Stephen
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 313 - 313
  • [10] Evidence cornered: Transfusion evidence summary-efficacy and safety of early administration of 4-factor prothrombin complex concentrate in patients with trauma at risk of massive transfusion-the PROCOAG randomised clinical trial (JAMA)
    Mccullagh, Josephine
    TRANSFUSION MEDICINE, 2024, 34 (03) : 169 - 171
12345